Why is Eiko Lifescience falling/rising?

As of 11-Jul, Eiko Lifesciences Ltd's stock price is currently at 56.00, reflecting a decrease of 0.75, or 1.32%. The stock has been underperforming recently, having fallen for three consecutive days, resulting in a total decline of 7.27% during this period. In the past week, the stock has experienced a significant drop of 10.34%, while over the last month, it has shown a positive return of 10.89%. Despite the recent downturn, there is a notable increase in promoter confidence, as they have raised their stake in the company by 4.96%, indicating a belief in the company's future prospects. However, the stock's long-term fundamentals remain weak, with a low average Return on Equity (ROE) of 2.82% and a concerning decline in net sales of 15.60% reported for the last quarter.
In the broader market context, Eiko Lifesciences' short-term performance has been notably worse than the benchmark, with a 10.34% decline compared to the Sensex's 1.12% drop over the same period. This underperformance is compounded by a significant decrease in investor participation, as evidenced by a 64.25% drop in delivery volume compared to the five-day average. While the stock has shown some positive movement over the past month, its year-to-date performance remains negative at -10.74%, contrasting sharply with the Sensex's gain of 5.58%. Overall, the combination of weak financial fundamentals, declining sales, and reduced investor interest contributes to the stock's current downward trajectory.